Piper Jaffray Upgrades Acorda Therapeutics, Inc. (ACOR) to Neutral
Tweet
Share
E-mailGet Alerts ACOR Hot Sheet
Price: $0.66 --0%
Rating Summary:
4 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Jaffray upgraded Acorda Therapeutics, Inc. (NASDAQ: ACOR) from Underweight to Neutral. PT increased from $21 to $30.
For more ratings news on Acorda Therapeutics, Inc. click here and for the rating history of Acorda Therapeutics, Inc. click here.
Shares of Acorda Therapeutics, Inc. closed at $30.38 yesterday.
For more ratings news on Acorda Therapeutics, Inc. click here and for the rating history of Acorda Therapeutics, Inc. click here.
Shares of Acorda Therapeutics, Inc. closed at $30.38 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
- Cantor Fitzgerald Upgrades Capricor Therapeutics (CAPR) to Overweight
- UBS Upgrades Pagegroup Plc. (PAGE:LN) (MPGPY) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
